Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
World Neurosurgery|September 3, 2018
Biopsy Versus Subtotal Versus Gross Total Resection in Patients with Low-Grade Glioma: A Systematic Review and Meta-AnalysisKaiyun Yang, Siddharth Nath, Alex Koziarz, et al.
Neuro-Oncology|January 17, 2019
Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of lifeFarshad Nassiri, Benjamin Price, Ameer Shehab, et al.
Neurosurgery|May 14, 2021
Evolution of the Neurosurgeon's Role in Clinical Trials for Glioblastoma: A Systematic Overview of the Clinicaltrials.Gov DatabaseAlireza Mansouri, Michelle E Beyn, Aditya Pancholi, et al.
Plos One|February 14, 2013
Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: an individual participant data meta-analysisAria Fallah, Gordon H Guyatt, O Carter Snead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma CellsSameer Agnihotri, Sheila Mansouri, Kelly Burrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2024
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical ApplicationNicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancerFabio Y Moraes, Alireza Mansouri, Archya Dasgupta, et al.
Neuro-Oncology Advances|July 10, 2026
Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trialsJohnny Duerinck, Louise Lescrauwaet, Philipp Karschnia, et al.
Laryngoscope Investigative Otolaryngology|October 20, 2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomasD Bradley Welling, Katharine A Collier, Sarah S Burns, et al.
Neuro-Oncology Advances|June 14, 2023
Suicidal ideation and attempts in brain tumor patients and survivors: A systematic reviewMohammad Mofatteh, Mohammad Sadegh Mashayekhi, Saman Arfaie, et al.
Pageof 17